Categories: Technology

Columbus Weekly report on share buyback

Company announcement no. 13/2025

Transactions in the period 21 July 2025 to 25 July 2025
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company
announcement no. 8/2025.

The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.

The following transactions were made under the share buyback programme in the period 21 July 2025 to 25 July 2025:

  Number of shares Average purchase price (DKK) Transaction value (DKK)
Accumulated, last announcement 164,056 10.46 1,716,758.50
21 July 2025 15,000 9.81 147,153.00
22 July 2025 18,000 9.82 176,679.00
23 July 2025 18,000 10.08 181,409.40
24 July 2015 15,000 10.09 151,306.50
25 July 2025 15,000 10.14 152,047.50
Total, 21 July 2025 to 25 July 2025 81,000 9.98 808,595.40
Total accumulated under the programme 245,056 10.31 2,525,353.90

With the transactions stated above, Columbus A/S holds a total of 245,056 own shares, corresponding to 0.19% of the Company’s share capital.

Ib Kunøe                        Søren Krogh Knudsen
Chairman of the Board                CEO & President

For further information, please contact:
CEO & President, Søren Krogh Knudsen, +45 70 20 50 00

GlobeNews Wire

Recent Posts

Singtel Receives Four Frost & Sullivan 2026 Recognitions for Leadership in Enterprise Connectivity, Cybersecurity, and Digital Transformation

The recognitions highlight Singtel's leadership in secure connectivity, network transformation, IoT innovation, and cybersecurity, delivering…

4 hours ago

4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population

July 18, 2026 15:15 ET  | Source: 4D Molecular Therapeutics, Inc. After a single intravitreal…

5 hours ago

Immuneering Corporation Announces Grants of Inducement Awards

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical…

5 hours ago

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

Silver Spring, MD, July 17, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration approved Lipfendra…

5 hours ago

Vitalist Announces Notice of Meeting & Record Date

CALGARY, Alberta, July 17, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. (TSX-V: VITA.V; OTCQB: VTLSF) ("Vitalist",…

10 hours ago

SPIRIT BLOCKCHAIN CAPITAL ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING AND BOARD CHANGES

July 17, 2026 17:00 ET  | Source: Spirit Blockchain Capital Inc. VANCOUVER, Canada, July 17,…

10 hours ago